Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$914.4M
Avg Funding
$36.6M
Global Reach
8
countries

Top Cities for Biopharma

San Francisco
Alexandria
Austin
South San Francisco
Montreal
Philadelphia

Recently Funded Companies

Export
San Francisco, United States

ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.

$13.2M raised
May 2026

Founder Contacts

41,000+ verified contacts

Alexandria, Australia

Federated Biologics is a biotechnology company that develops treatment drugs through cell culture manufacturing.

$6.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Austin, United States

Modicus Prime enables pharmaceutical manufacturers to deploy AI systems that are auditable and compliant by design.

$4.5M raised
May 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

May 2026

Founder Contacts

41,000+ verified contacts

Montreal, Canada

CELYSTRA Pharma identifies, licenses, and commercializes innovative therapies for rare and underserved diseases in Canada.

$14.7M raised
May 2026

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

$43.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Malvern, United States

Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.

$115.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Dover, United States

Locksmith Bio is a biotechnology company that uses AI to map intrinsically disordered protein for novel drug discovery.

$1.9M raised
May 2026

Founder Contacts

41,000+ verified contacts

Santa Barbara, United States

CancerVAX Biotech is a biotechnology company that develops universal cancer treatment using the body’s immune system.

$903K raised
May 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

BioOrbit is a space manufacturing firm that develops hardware for large-scale protein drug crystallization.

$13.2M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Dublin, Ireland

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

$117.5M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Heverlee, Belgium

CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.

$125.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.

$47.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Entelo bio is a computational biotech company building the engine for functional cell profiling and novel target discovery.

$4.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Vestec, Czech Republic

DIANA Biotechnologies specializes in the development of products based on research in clinical diagnostics and drug discovery areas.

Apr 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

$150.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Iselin, United States

Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.

$5.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Wilmington, United States

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

$90.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

$60.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

San Juan, Puerto Rico

Aspire Biopharma is a biotechnology company that develops nano technology drug formulation technology and medicinal products.

$22.5M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Adelaide, Australia

BiomeBank is a clinical stage biotechnology company developing microbial therapies

$10.8M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Waltham, United States

Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.

$40.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Baltimore, United States

Aletira is an emerging biotechnology company based on technologies created at Johns Hopkins University.

$300K raised
Apr 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Enjamb Labs is an AI platform that streamlines drug development, clinical research, and regulatory processes for biopharma teams.

Apr 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

$30.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Showing 126 to 150 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$36.6M
Total Funding Tracked
$914.4M
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.South San Francisco
3 companies$210.0M
2.San Francisco
2 companies$13.2M
3.Alexandria
1 companies$6.0M
4.Austin
1 companies$4.5M
5.Montreal
1 companies$14.7M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked